Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...

Full description

Saved in:
Bibliographic Details
Published in:World J Gastroenterol
Main Authors: Takahashi, Yoshihisa, Sugimoto, Keiichiro, Inui, Hiroshi, Fukusato, Toshio
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2015
Subjects:
Editorial
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/
https://ncbi.nlm.nih.gov/pubmed/25852263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items